CORC  > 兰州大学  > 兰州大学  > 第一临床医学院  > 期刊论文
Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers
Zhang, YF; Dai, XJ; Yang, Y; Chen, XY; Wang, T; Tang, YB; Tsai, CY; Chang, LW; Chang, YT; Zhong, DF
刊名DRUG DESIGN DEVELOPMENT AND THERAPY
2016
卷号10页码:357-370
关键词nemonoxacin probenecid cimetidine clinical pharmacokinetics drug-drug interaction
ISSN号1177-8881
文献子类Article
英文摘要Purpose: To investigate the effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in humans. Methods: Two independent, open-label, randomized, crossover studies were conducted in 24 (12 per study) healthy Chinese volunteers. In Study 1, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with 1.5 g of probenecid divided into three doses within 25 hours. In Study 2, each volunteer received a single oral dose of 500 mg of nemonoxacin alone or with multiple doses of cimetidine (400 mg thrice daily for 7 days). The plasma and urine nemonoxacin concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. Results: Coadministration of nemonoxacin with probenecid reduced the renal clearance (CLr) of nemonoxacin by 22.6%, and increased the area under the plasma concentration-time curve from time 0 to infinity (AUC(0-8)) by 26.2%. Coadministration of nemonoxacin with cimetidine reduced the CLr of nemonoxacin by 13.3% and increased AUC(0-8) by 9.4%. Coadministration of nemonoxacin with probenecid or cimetidine did not significantly affect the maximum concentration of nemonoxacin or the percentage of the administered dose recovered in the urine. Conclusion: Although probenecid reduced the CLr and increased the plasma exposure of nemonoxacin, these effects are unlikely to be clinically meaningful at therapeutic doses. Cimetidine had weaker, clinically meaningless effects on the pharmacokinetics of nemonoxacin.
学科主题Pharmacology & Pharmacy
出版地ALBANY
资助项目国家科技重大专项
项目编号National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2012ZX0931-001]
语种英语
WOS记录号WOS:000368487900003
资助机构MOST
内容类型期刊论文
源URL[http://ir.lzu.edu.cn/handle/262010/178542]  
专题第一临床医学院_期刊论文
通讯作者Zhong, DF (reprint author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China.
推荐引用方式
GB/T 7714
Zhang, YF,Dai, XJ,Yang, Y,et al. Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2016,10:357-370.
APA Zhang, YF.,Dai, XJ.,Yang, Y.,Chen, XY.,Wang, T.,...&Zhong, DF .(2016).Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers.DRUG DESIGN DEVELOPMENT AND THERAPY,10,357-370.
MLA Zhang, YF,et al."Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers".DRUG DESIGN DEVELOPMENT AND THERAPY 10(2016):357-370.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace